Pioneering Skin Bioprinting
Discover Our Cutting-Edge Innovation Driven Technology
Our scientific process
1
Pre-Processing
12 ONGOING RESEARCH PROJECTS
Use this space to promote the business, its products or its services. Help people become familiar with the business and its offerings, creating a sense of connection and trust. Focus on what makes the business unique and how users can benefit from choosing it.
2
3D Bioprinting
5 ONGOING RESEARCH PROJECTS
Use this space to promote the business, its products or its services. Help people become familiar with the business and its offerings, creating a sense of connection and trust. Focus on what makes the business unique and how users can benefit from choosing it.
3
Post-processing and Applications
8 ONGOING RESEARCH PROJECTS
Use this space to promote the business, its products or its services. Help people become familiar with the business and its offerings, creating a sense of connection and trust. Focus on what makes the business unique and how users can benefit from choosing it.
Publications
BioPrintSkin Group
UCL consistently ranks among the world's top institutions for medicine and life sciences. In the QS World University Rankings by Subject 2024, UCL was placed 6th globally for Medicine and 4th for Pharmacy and Pharmacology, underscoring its leadership in these fields.
The group has a distinguished history in developing tissue-engineered skin equivalents and neural tubes. By integrating cutting-edge biomaterials with cellular biology, they have created constructs that closely mimic the structure and function of natural tissues, offering promising solutions for regenerative medicine and reconstructive surgery.
Materials & Design
Ceramic materials for 3D printing of biomimetic bone scaffolds – Current state-of-the-art & future perspectives
UK Parliament Post
3D bioprinting in medicine
Review
Literature Review on Bioprinted Skin EquivalentsBiostimulating soft tissue fillers such as calcium hydroxyapatite, poly-L-lactic acid, poly-D,L-lactic acid, and polycaprolactone offer diverse options for facial rejuvenation. Each filler possesses unique rheological properties and clinical applications, making them suitable for different aesthetic goals. As the field of aesthetic medicine continues to evolve, ongoing research will further elucidate the efficacy and safety profiles of these fillers, ultimately enhancing patient outcomes.
Update on Rheology of Hyaluronic Acid Soft Tissue Fillers
Biostimulating Soft Tissue Fillers : An UpdateThe group actively explores the role of extracellular vesicles (EVs) in tissue repair and regeneration. EVs are biological nanoparticles naturally secreted by cells, acting as delivery vehicles for molecular messages. Their research aims to harness EVs' potential in facilitating communication between cells, thereby improving the integration and functionality of bioprinted tissues.
Exosomes Update UCL
Human derived & plant derived Extracellualr VesiclesUnderstanding the epigenetic regulation of gene expression is crucial for tissue-engineering. The group's has initiated research into microRNAs—small non-coding RNAs that play a significant role in gene regulation—provides insights into cellular behavior and differentiation.This knowledge is instrumental in designing bioprinted skin equivalents that emulate the dynamic nature of human skin.
MicroRNA in Skin RegenerationThe integration of intravenous ADRC administration into pre-flight protocols represents a promising strategy to combat osteoporosis in astronauts. By harnessing the regenerative potential of these cells, it may be possible to counteract the detrimental effects of microgravity on bone health, thereby ensuring the safety and well-being of crew members during extended space missions.
Space Travel and ADRC
Regeneration for the frontal frontier
Ali Pirayesh
MD MRCS PhD FCC(Plast)
Ali Pirayesh MD PhD is an associate professor with the Department of Surgical Biotechnology in the UCL Division of Surgery & Interventional Science and a renowned consultant plastic reconstructive and aesthetic surgeon. He is owner of Amsterdam Plastic Surgery private clinic (NL) and Zurich Plastic Surgery (Bad Ragaz / Zürich CH).
Ash Mosahebi
MBBS FRCS PhD MBA FRCS(Plast)
Professor Ash Mosahebi is a chair at the Department of Surgical Biotechnology in the UCL Division of Surgery & Interventional Science and a renowned consultant plastic reconstructive and aesthetic surgeon at University College London & Royal Free Hospitals NHS trust with a special interest in complex breast reconstruction.
Colin Morrison
MBBS FRCS (Plast)
Mr Morrison completed a Breast & Aesthetic Fellowship at the Cleveland Clinic and was subsequently appointed Consultant Plastic Surgeon at Addenbrooke’s Hospital, Cambridge, returning to Ireland in 2011 to establish the microsurgical service at St. Vincent’s University Hospital and St. Vincent’s Private Hospital.
Deepak Kalaskar
PhD
Professor Kalaskar is a multidisciplinary scientist with extensive experience in research, management and teaching in the area of biomedical engineering, chemistry, biological sciences, biomaterials and 3D fabrication technologies.
Professor Kalaskar brings in extensive experience in biomaterials and 3D printing technologies.
Our Founders
The UCL Surgical Biotechnology Scientists and PARS-Ul Clinicians are the backbone of Bioprint Skin Group and stand at the forefront of biomedical innovation, uniting basic scientists, senior researchers, and plastic surgeons in a collaborative effort to replicate, restore and regenerate native human skin, our largest organ through state of the art tissue-engineering techniques.